B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DRD2

MOLECULAR TARGET

dopamine receptor D2

UniProt: P14416NCBI Gene: 1813114 compounds

DRD2 (dopamine receptor D2) is targeted by 114 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DRD2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Raclopride3.4029
2Buspirone3.2625
3Domperidone2.9418
4Metoclopramide2.8917
5Pergolide2.8316
6Pramipexole2.8316
7Aripiprazole2.7715
8Sulpiride2.7114
9Bromocriptine2.4811
10Butaclamol2.4811
11Amoxapine2.4010
12Amisulpride2.309
13Levalbuterol2.208
14Levalbuterol2.208
15Phenoxybenzamine2.208
16Yohimbine2.208
17Cyproheptadine2.087
18Perphenazine2.087
19Flunarizine Flunarizine is1.956
20Fluspirilene1.956
21Loxapine1.956
22oxatomide [Supplementary Concept] structure;1.956
23Mianserin1.795
24Quetiapine Fumarate1.795
25Dihydroergotamine1.795
26Lisuride1.795
27Metergoline1.795
28pirenperone1.795
29Thioridazine1.795
30Tiapride Hydrochloride1.795
31triflupromazine hydrochloride1.795
32Adenosine Monophosphate Adenine nucleotide containing1.614
33Clenbuterol1.614
34Cyclic AMP1.614
35Cyclic AMP1.614
36Deferasirox1.614
37Dinoprostone1.614
38Epinephrine1.614
39Etodolac1.614
40Isopentenyladenosine N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is1.614
41Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on1.614
42Loxapine1.614
43Nicergoline1.614
44Norepinephrine Precursor of epinephrine that is secreted by1.614
45Nylidrin1.614
46Piribedil1.614
47Promazine1.614
48propionylpromazine hydrochloride1.614
49Ranitidine1.614
50Salmeterol Xinafoate1.614

Showing top 50 of 114 compounds. Use the BiohacksAI search to explore all DRD2 modulators.

About DRD2 as a Drug Target

DRD2 (dopamine receptor D2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 114 compounds with documented DRD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DRD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.